These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30791746)

  • 1. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sweetman E; Ryan M; Edgar C; MacKay A; Vallings R; Tate W
    Int J Immunopathol Pharmacol; 2019; 33():2058738418820402. PubMed ID: 30791746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
    Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
    Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
    J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM
    J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat treatment in health and disease: How water-filtered infrared-A (wIRA) irradiation affects key cellular mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients compared to healthy donors.
    Hochecker B; Molinski N; Matt K; Meßmer A; Scherer M; von Ardenne A; Bergemann J
    J Therm Biol; 2024 Feb; 120():103813. PubMed ID: 38412735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy.
    Xu J; Potter M; Tomas C; Elson JL; Morten KJ; Poulton J; Wang N; Jin H; Hou Z; Huang WE
    Analyst; 2019 Jan; 144(3):913-920. PubMed ID: 30207334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Missailidis D; Sanislav O; Allan CY; Annesley SJ; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study.
    Jahanbani F; Maynard RD; Sing JC; Jahanbani S; Perrino JJ; Spacek DV; Davis RW; Snyder MP
    PLoS One; 2022; 17(8):e0272703. PubMed ID: 35943990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts.
    Missailidis D; Sanislav O; Allan CY; Smith PK; Annesley SJ; Fisher PR
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome.
    Walitt B; Singh K; LaMunion SR; Hallett M; Jacobson S; Chen K; Enose-Akahata Y; Apps R; Barb JJ; Bedard P; Brychta RJ; Buckley AW; Burbelo PD; Calco B; Cathay B; Chen L; Chigurupati S; Chen J; Cheung F; Chin LMK; Coleman BW; Courville AB; Deming MS; Drinkard B; Feng LR; Ferrucci L; Gabel SA; Gavin A; Goldstein DS; Hassanzadeh S; Horan SC; Horovitz SG; Johnson KR; Govan AJ; Knutson KM; Kreskow JD; Levin M; Lyons JJ; Madian N; Malik N; Mammen AL; McCulloch JA; McGurrin PM; Milner JD; Moaddel R; Mueller GA; Mukherjee A; Muñoz-Braceras S; Norato G; Pak K; Pinal-Fernandez I; Popa T; Reoma LB; Sack MN; Safavi F; Saligan LN; Sellers BA; Sinclair S; Smith B; Snow J; Solin S; Stussman BJ; Trinchieri G; Turner SA; Vetter CS; Vial F; Vizioli C; Williams A; Yang SB; ; Nath A
    Nat Commun; 2024 Feb; 15(1):907. PubMed ID: 38383456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function.
    Tomas C; Elson JL; Strassheim V; Newton JL; Walker M
    PLoS One; 2020; 15(4):e0231136. PubMed ID: 32275686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
    Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
    J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.